Fingerprint
Dive into the research topics of 'A phase II trial of Triapine® (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically